Publications

Publications by Tom Eirik Mollnes

346 publications found

Publications in press

1. Haugaa H, Thorgersen EB, Pharo A, Boberg KM, Foss A, Line PD, Sanengen T, Almaas R, Grindheim G, Pischke SE, Mollnes TE, Tønnessen TI
   Early bedside detection of ischemia and rejection in liver transplants by microdialysis
   Liver Transpl (in press)
   PubMed 22407878
2. Kvarnström A, Sokolov A, Swartling T, Kurlberg G, Mollnes TE, Bengtsson A
   Alternative pathway activation of complement in laparoscopic and open rectal surgery
   Scand J Immunol (in press)
   PubMed 22486843
3. Orn S, Ueland T, Manhenke C, Sandanger O, Godang K, Yndestad A, Mollnes TE, Dickstein K, Aukrust P
   Increased interleukin-1? levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention
   J Intern Med (in press)
   PubMed 22243053

Publications 2012

1. Almaas R, Hankø E, Mollnes TE, Rootwelt T (2012)
   Dexamethasone reduces bilirubin-induced toxicity and IL-8 and MCP-1 release in human NT2-N neurons
   Brain Res, 1458, 12-7
   PubMed 22546346
2. Bisschops LL, Hoedemaekers CW, Mollnes TE, van der Hoeven JG (2012)
   Rewarming after hypothermia after cardiac arrest shifts the inflammatory balance
   Crit Care Med, 40 (4), 1136-42
   PubMed 22020246
3. Christiansen D, Brekke OL, Stenvik J, Lambris JD, Espevik T, Mollnes TE (2012)
   Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human blood
   Adv Exp Med Biol, 946, 237-51
   PubMed 21948372
4. Hovland A, Hardersen R, Nielsen EW, Enebakk T, Christiansen D, Ludviksen JK, Mollnes TE, Lappegård KT (2012)
   Complement profile and activation mechanisms by different LDL apheresis systems
   Acta Biomater, 8 (6), 2288-96
   PubMed 22373816
5. Hovland A, Marcovina S, Hardersen R, Enebakk T, Mollnes TE, Lappegård KT (2012)
   Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles
   Transfus Apher Sci, 46 (1), 73-6
   PubMed 22206792
6. Sokolov A, Hellerud BC, Johannessen EA, Mollnes TE (2012)
   Inflammatory response induced by candidate biomaterials of an implantable microfabricated sensor
   J Biomed Mater Res A, 100 (5), 1142-50
   PubMed 22337626

Publications 2011

1. Barratt-Due A, Johansen HT, Sokolov A, Thorgersen EB, Hellerud BC, Reubsaet JL, Seip KF, Tønnessen TI, Lindstad JK, Pharo A, Castellheim A, Mollnes TE, Nielsen EW (2011)
   The role of bradykinin and the effect of the bradykinin receptor antagonist icatibant in porcine sepsis
   Shock, 36 (5), 517-23
   PubMed 21921836
2. Barratt-Due A, Thorgersen EB, Lindstad JK, Pharo A, Lissina O, Lambris JD, Nunn MA, Mollnes TE (2011)
   Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humans
   J Immunol, 187 (9), 4913-9
   PubMed 21964028
3. Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
   Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
   J Infect, 63 (4), 308-16
   PubMed 21781987
4. Bergseth G, Lambris JD, Mollnes TE, Lappegård KT (2011)
   Artificial surface-induced inflammation relies on complement factor 5: proof from a deficient person
   Ann Thorac Surg, 91 (2), 527-33
   PubMed 21256307
5. Brekke OL, Hellerud BC, Christiansen D, Fure H, Castellheim A, Nielsen EW, Pharo A, Lindstad JK, Bergseth G, Leslie G, Lambris JD, Brandtzaeg P, Mollnes TE (2011)
   Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood
   Mol Immunol, 48 (15-16), 2159-69
   PubMed 21839519
6. Chavez SA, Martinko AJ, Lau C, Pham MN, Cheng K, Bevan DE, Mollnes TE, Yin H (2011)
   Development of ?-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics
   J Med Chem, 54 (13), 4659-69
   PubMed 21591694
7. Fredheim EG, Granslo HN, Flægstad T, Figenschau Y, Rohde H, Sadovskaya I, Mollnes TE, Klingenberg C (2011)
   Staphylococcus epidermidis polysaccharide intercellular adhesin activates complement
   FEMS Immunol Med Microbiol, 63 (2), 269-80
   PubMed 22077230
8. Grimnes G, Beckman H, Lappegård KT, Mollnes TE, Skogen V (2011)
   Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report
   APMIS, 119 (7), 479-84
   PubMed 21635555
9. Harboe M, Thorgersen EB, Mollnes TE (2011)
   Advances in assay of complement function and activation
   Adv Drug Deliv Rev, 63 (12), 976-87
   PubMed 21664392
10. Hovland A, Hardersen R, Enebakk T, Mollnes TE, Lappegård KT (2011)
    Patient tolerance regarding different low-density lipoprotein apheresis columns: frequent minor side effects and high patient satisfaction
    J Clin Lipidol, 5 (1), 45-9
    PubMed 21262506
11. Rokstad AM, Brekke OL, Steinkjer B, Ryan L, Kolláriková G, Strand BL, Skjåk-Bræk G, Lacík I, Espevik T, Mollnes TE (2011)
    Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model
    Acta Biomater, 7 (6), 2566-78
    PubMed 21402181
12. Sokolov A, Hellerud BC, Lambris JD, Johannessen EA, Mollnes TE (2011)
    Activation of polymorphonuclear leukocytes by candidate biomaterials for an implantable glucose sensor
    J Diabetes Sci Technol, 5 (6), 1490-8
    PubMed 22226271
13. Sokolov A, Hellerud BC, Pharo A, Johannessen EA, Mollnes TE (2011)
    Complement activation by candidate biomaterials of an implantable microfabricated medical device
    J Biomed Mater Res B Appl Biomater, 98B (2), 323-9
    PubMed 21648060
14. Søyland E, Heier I, Rodríguez-Gallego C, Mollnes TE, Johansen FE, Holven KB, Halvorsen B, Aukrust P, Jahnsen FL, de la Rosa Carrillo D, Krogstad AL, Nenseter MS (2011)
    Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis
    Br J Dermatol, 164 (2), 344-55
    PubMed 21271993
15. Thiara AS, Mollnes TE, Videm V, Andersen VY, Svennevig K, Kolset SO, Fiane AE (2011)
    Biocompatibility and pathways of initial complement pathway activation with Phisio- and PMEA-coated cardiopulmonary bypass circuits during open-heart surgery
    Perfusion, 26 (2), 107-14
    PubMed 21177724
16. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
    The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
    Scand J Immunol, 74 (6), 632-9
    PubMed 21883353
17. van Kuilenburg J, Lappegård KT, Sexton J, Plesiewicz I, Lap P, Bouwels L, Sprong T, Mollnes TE, Verheugt F, van Heerde WL, Pop GA (2011)
    Persisting thrombin activity in elderly patients with atrial fibrillation on oral anticoagulation is decreased by anti-inflammatory therapy with intensive cholesterol-lowering treatment
    J Clin Lipidol, 5 (4), 273-80
    PubMed 21784372
18. Wester T, Häggblad E, Awan ZA, Barratt-Due A, Kvernebo M, Halvorsen PS, Mollnes TE, Kvernebo K (2011)
    Assessments of skin and tongue microcirculation reveals major changes in porcine sepsis
    Clin Physiol Funct Imaging, 31 (2), 151-8
    PubMed 21087397

Publications 2010

1. Barratt-Due A, Thorgersen EB, Lindstad JK, Pharo A, Brekke OL, Christiansen D, Lambris JD, Mollnes TE (2010)
   Selective inhibition of TNF-alpha or IL-1 beta does not affect E. coli-induced inflammation in human whole blood
   Mol Immunol, 47 (9), 1774-82
   PubMed 20334922
2. Dalen ML, Alme TN, Munkeby BH, Løberg EM, Pripp AH, Mollnes TE, Rootwelt T, Saugstad OD (2010)
   Early protective effect of hypothermia in newborn pigs after hyperoxic, but not after normoxic, reoxygenation
   J Perinat Med, 38 (5), 545-56
   PubMed 20629493
3. Eagan TM, Aukrust P, Bakke PS, Damås JK, Skorge TD, Hardie JA, Ueland T, Mollnes TE (2010)
   Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease
   Respir Med, 104 (2), 283-90
   PubMed 19836222
4. Eagan TM, Aukrust P, Ueland T, Hardie JA, Johannessen A, Mollnes TE, Damås JK, Bakke PS, Wagner PD (2010)
   Body composition and plasma levels of inflammatory biomarkers in COPD
   Eur Respir J, 36 (5), 1027-33
   PubMed 20413541
5. Eagan TM, Damås JK, Ueland T, Voll-Aanerud M, Mollnes TE, Hardie JA, Bakke PS, Aukrust P (2010)
   Neutrophil gelatinase-associated lipocalin: a biomarker in COPD
   Chest, 138 (4), 888-95
   PubMed 20495108
6. Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, Aukrust P, Bakke PS (2010)
   Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
   Eur Respir J, 35 (3), 540-8
   PubMed 19643942
7. Eggum R, Ueland T, Mollnes TE, Videm V, Fiane AE, Aukrust P, Lindberg HL (2010)
   Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery
   Interact Cardiovasc Thorac Surg, 10 (1), 76-80
   PubMed 19822605
8. Granslo HN, Klingenberg C, Fredheim EG, Rønnestad A, Mollnes TE, Flaegstad T (2010)
   Arginine catabolic mobile element is associated with low antibiotic resistance and low pathogenicity in Staphylococcus epidermidis from neonates
   Pediatr Res, 68 (3), 237-41
   PubMed 20703143
9. Hellerud BC, Nielsen EW, Thorgersen EB, Lindstad JK, Pharo A, Tønnessen TI, Castellheim A, Mollnes TE, Brandtzaeg P (2010)
   Dissecting the effects of lipopolysaccharides from nonlipopolysaccharide molecules in experimental porcine meningococcal sepsis
   Crit Care Med, 38 (6), 1467-74
   PubMed 20400898
10. Hellerud BC, Aase A, Herstad TK, Naess LM, Kristiansen LH, Trøseid AM, Harboe M, Lappegård KT, Brandtzaeg P, Høiby EA, Mollnes TE (2010)
    Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies
    Infect Immun, 78 (2), 802-9
    PubMed 19933829
11. Hoedemaekers C, van Deuren M, Sprong T, Pickkers P, Mollnes TE, Klasen I, van der Hoeven J (2010)
    The complement system is activated in a biphasic pattern after coronary artery bypass grafting
    Ann Thorac Surg, 89 (3), 710-6
    PubMed 20172115
12. Hovland A, Hardersen R, Mollnes TE, Lappegård KT (2010)
    Selective whole blood lipoprotein apheresis to prevent pancreatitis in drug refractory hypertriglyceridemia
    JOP, 11 (5), 467-9
    PubMed 20818118
13. Hovland A, Hardersen R, Nielsen EW, Mollnes TE, Lappegård KT (2010)
    Hematologic and hemostatic changes induced by different columns during LDL apheresis
    J Clin Apher, 25 (5), 294-300
    PubMed 20806414
14. Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E, Mollnes TE, Bakke O, Espevik T (2010)
    The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes
    Immunity, 33 (4), 583-96
    PubMed 20933442
15. Johannessen E, Krushinitskaya O, Sokolov A, Philipp H, Hoogerwerf A, Hinderling C, Kautio K, Lenkkeri J, Strömmer E, Kondratyev V, Tønnessen TI, Mollnes TE, Jakobsen H, Zimmer E, Akselsen B (2010)
    Toward an injectable continuous osmotic glucose sensor
    J Diabetes Sci Technol, 4 (4), 882-92
    PubMed 20663452
16. Kourtzelis I, Markiewski MM, Doumas M, Rafail S, Kambas K, Mitroulis I, Panagoutsos S, Passadakis P, Vargemezis V, Magotti P, Qu H, Mollnes TE, Ritis K, Lambris JD (2010)
    Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis
    Blood, 116 (4), 631-9
    PubMed 20424189
17. Salvesen B, Stenvik J, Rossetti C, Saugstad OD, Espevik T, Mollnes TE (2010)
    Meconium-induced release of cytokines is mediated by the TRL4/MD-2 complex in a CD14-dependent manner
    Mol Immunol, 47 (6), 1226-34
    PubMed 20092898
18. Silasi-Mansat R, Zhu H, Popescu NI, Peer G, Sfyroera G, Magotti P, Ivanciu L, Lupu C, Mollnes TE, Taylor FB, Kinasewitz G, Lambris JD, Lupu F (2010)
    Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis
    Blood, 116 (6), 1002-10
    PubMed 20466856
19. Thiara AS, Andersen VY, Videm V, Mollnes TE, Svennevig K, Hoel TN, Fiane AE (2010)
    Comparable biocompatibility of Phisio- and Bioline-coated cardiopulmonary bypass circuits indicated by the inflammatory response
    Perfusion, 25 (1), 9-16
    PubMed 20172900
20. Thorgersen EB, Hellerud BC, Nielsen EW, Barratt-Due A, Fure H, Lindstad JK, Pharo A, Fosse E, Tønnessen TI, Johansen HT, Castellheim A, Mollnes TE (2010)
    CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs
    FASEB J, 24 (3), 712-22
    PubMed 19841036
21. Thorgersen EB, Ludviksen JK, Lambris JD, Sfyroera G, Nielsen EW, Mollnes TE (2010)
    Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity
    Innate Immun, 16 (4), 254-64
    PubMed 19710096

Publications 2009

1. Bexborn F, Engberg AE, Sandholm K, Mollnes TE, Hong J, Nilsson Ekdahl K (2009)
   Hirudin versus heparin for use in whole blood in vitro biocompatibility models
   J Biomed Mater Res A, 89 (4), 951-9
   PubMed 18470919
2. Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE (2009)
   Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis
   Scand J Immunol, 69 (6), 479-91
   PubMed 19439008
3. Corallini F, Bossi F, Gonelli A, Tripodo C, Castellino G, Mollnes TE, Tedesco F, Rizzi L, Trotta F, Zauli G, Secchiero P (2009)
   The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis
   Rheumatology (Oxford), 48 (3), 293-8
   PubMed 19168833
4. Dalen ML, Frøyland E, Saugstad OD, Mollnes TE, Rootwelt T (2009)
   Post-hypoxic hypothermia is protective in human NT2-N neurons regardless of oxygen concentration during reoxygenation
   Brain Res, 1259, 80-9
   PubMed 19146835
5. Harboe M, Garred P, Karlstrøm E, Lindstad JK, Stahl GL, Mollnes TE (2009)
   The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification
   Mol Immunol, 47 (2-3), 373-80
   PubMed 19800125
6. Hoel TN, Thiara AS, Videm V, Fiane AE, Mollnes TE, Castellheim A, Svennevig JL (2009)
   In vitro evaluation of PHISIO-coated sets for pediatric cardiac surgery
   Scand Cardiovasc J, 43 (2), 129-35
   PubMed 19294579
7. Hovland A, Hardersen R, Sexton J, Mollnes TE, Lappegård KT (2009)
   Different inflammatory responses induced by three LDL-lowering apheresis columns
   J Clin Apher, 24 (6), 247-53
   PubMed 19927364
8. Kåsin JI, Kjekshus J, Aukrust P, Mollnes TE, Wagstaff A (2009)
   A helicopter flight does not induce significant changes in systemic biomarker profiles
   Scand J Clin Lab Invest, 69 (4), 462-74
   PubMed 19333819
9. Lappegård KT, Christiansen D, Pharo A, Thorgersen EB, Hellerud BC, Lindstad J, Nielsen EW, Bergseth G, Fadnes D, Abrahamsen TG, Høiby EA, Schejbel L, Garred P, Lambris JD, Harboe M, Mollnes TE (2009)
   Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature
   Proc Natl Acad Sci U S A, 106 (37), 15861-6
   PubMed 19717455
10. Manderson GA, Martin M, Onnerfjord P, Saxne T, Schmidtchen A, Mollnes TE, Heinegård D, Blom AM (2009)
    Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system
    Mol Immunol, 46 (16), 3388-98
    PubMed 19674792
11. Martin M, Gottsäter A, Nilsson PM, Mollnes TE, Lindblad B, Blom AM (2009)
    Complement activation and plasma levels of C4b-binding protein in critical limb ischemia patients
    J Vasc Surg, 50 (1), 100-6
    PubMed 19563958
12. Natvig JB, Mollnes TE (2009)
    Professor emeritus Morten Harboe, one of the founders of Scandinavian Journal of Immunology, turns 80
    Scand. J. Immunol., 69 (6), 469-470
13. Nielsen EW, Hellerud BC, Thorgersen EB, Castellheim A, Pharo A, Lindstad J, Tønnessen TI, Brandtzaeg P, Mollnes TE (2009)
    A new dynamic porcine model of meningococcal shock
    Shock, 32 (3), 302-9
    PubMed 19174740
14. Orn S, Breland UM, Mollnes TE, Manhenke C, Dickstein K, Aukrust P, Ueland T (2009)
    The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction
    Am J Cardiol, 104 (9), 1179-83
    PubMed 19840558
15. Pedersen ED, Løberg EM, Vege E, Daha MR, Maehlen J, Mollnes TE (2009)
    In situ deposition of complement in human acute brain ischaemia
    Scand J Immunol, 69 (6), 555-62
    PubMed 19439017
16. Salvesen B, Mollnes TE (2009)
    Pathway-specific complement activity in pigs evaluated with a human functional complement assay
    Mol Immunol, 46 (8-9), 1620-5
    PubMed 19328551
17. Salvesen B, Nielsen EW, Harboe M, Saugstad OD, Mollnes TE (2009)
    Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood
    Mol Immunol, 46 (4), 688-94
    PubMed 18950866
18. Siezenga MA, Chandie Shaw PK, van der Geest RN, Mollnes TE, Daha MR, Rabelink TJ, Berger SP (2009)
    Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians
    Clin Exp Immunol, 157 (1), 98-103
    PubMed 19659775
19. Sikkeland LI, Eduard W, Stangeland AM, Thorgersen EB, Haug T, Aukrust P, Halvorsen B, Mollnes TE, Kongerud J (2009)
    Occupational exposure to bacterial single cell protein induces inflammation in lung and blood
    Inhal Toxicol, 21 (8), 674-81
    PubMed 19558225
20. Sprong T, Mollnes TE, Neeleman C, Swinkels D, Netea MG, van der Meer JW, van Deuren M (2009)
    Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock
    Clin Infect Dis, 49 (9), 1380-6
    PubMed 19793001
21. Thorgersen EB, Pharo A, Haverson K, Axelsen AK, Gaustad P, Kotwal GJ, Sfyroera G, Mollnes TE (2009)
    Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood
    Infect Immun, 77 (2), 725-32
    PubMed 19047409
22. Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2009)
    The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome
    Metab Syndr Relat Disord, 7 (6), 579-84
    PubMed 19900154
23. Ørn S, Manhenke C, Ueland T, Damås JK, Mollnes TE, Edvardsen T, Aukrust P, Dickstein K (2009)
    C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
    Eur Heart J, 30 (10), 1180-6
    PubMed 19299430

Publications 2008

1. Asberg AE, Mollnes TE, Videm V (2008)
   Complement activation by neutrophil granulocytes
   Scand J Immunol, 67 (4), 354-61
   PubMed 18248527
2. Brekke OL, Christiansen D, Fure H, Pharo A, Fung M, Riesenfeld J, Mollnes TE (2008)
   Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood
   Mol Immunol, 45 (14), 3804-13
   PubMed 18606453
3. Castellheim A, Hoel TN, Videm V, Fosse E, Pharo A, Svennevig JL, Fiane AE, Mollnes TE (2008)
   Biomarker profile in off-pump and on-pump coronary artery bypass grafting surgery in low-risk patients
   Ann Thorac Surg, 85 (6), 1994-2002
   PubMed 18498809
4. Castellheim A, Thorgersen EB, Hellerud BC, Pharo A, Johansen HT, Brosstad F, Gaustad P, Brun H, Fosse E, Tønnessen TI, Nielsen EW, Mollnes TE (2008)
   New biomarkers in an acute model of live Escherichia coli-induced sepsis in pigs
   Scand J Immunol, 68 (1), 75-84
   PubMed 18466195
5. Eggum R, Ueland T, Mollnes TE, Videm V, Aukrust P, Fiane AE, Lindberg HL (2008)
   Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery
   Ann Thorac Surg, 85 (2), 611-7
   PubMed 18222275
6. Harboe M, Mollnes TE (2008)
   The alternative complement pathway revisited
   J Cell Mol Med, 12 (4), 1074-84
   PubMed 18419792
7. Hellerud BC, Stenvik J, Espevik T, Lambris JD, Mollnes TE, Brandtzaeg P (2008)
   Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation
   Infect Immun, 76 (9), 4183-9
   PubMed 18591229
8. Lappegård KT, Bergseth G, Riesenfeld J, Pharo A, Magotti P, Lambris JD, Mollnes TE (2008)
   The artificial surface-induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent
   J Biomed Mater Res A, 87 (1), 129-35
   PubMed 18085644
9. Mollnes TE (2008)
   High mobility group box-1 protein--one step closer to the clinic?
   Crit Care, 12 (4), 168
   PubMed 18671827
10. Mollnes TE, Castellheim A, Lindenskov PH, Salvesen B, Saugstad OD (2008)
    The role of complement in meconium aspiration syndrome
    J Perinatol, 28 Suppl 3, S116-9
    PubMed 19057601
11. Mollnes TE, Christiansen D, Brekke OL, Espevik T (2008)
    Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response
    Adv Exp Med Biol, 632, 253-63
    PubMed 19025127
12. Saethre M, Schneider MK, Lambris JD, Magotti P, Haraldsen G, Seebach JD, Mollnes TE (2008)
    Cytokine secretion depends on Galalpha(1,3)Gal expression in a pig-to-human whole blood model
    J Immunol, 180 (9), 6346-53
    PubMed 18424758
13. Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
    Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
    Nephrol Dial Transplant, 23 (12), 4054-60
    PubMed 18577532
14. Salvesen B, Fung M, Saugstad OD, Mollnes TE (2008)
    Role of complement and CD14 in meconium-induced cytokine formation
    Pediatrics, 121 (3), e496-505
    PubMed 18299306
15. Salvesen B, Mollnes TE, Saugstad OD (2008)
    Albumin lavage does not improve the outcome of meconium aspiration syndrome
    J Matern Fetal Neonatal Med, 21 (10), 719-25
    PubMed 19012188
16. Thorgersen EB, Macagno A, Rossetti C, Mollnes TE (2008)
    Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig
    Mol Immunol, 45 (13), 3553-7
    PubMed 18571239
17. Waelgaard L, Thorgersen EB, Line PD, Foss A, Mollnes TE, Tønnessen TI (2008)
    Microdialysis monitoring of liver grafts by metabolic parameters, cytokine production, and complement activation
    Transplantation, 86 (8), 1096-103
    PubMed 18946348

Publications 2007

1. Brekke OL, Christiansen D, Fure H, Fung M, Mollnes TE (2007)
   The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood
   J Leukoc Biol, 81 (6), 1404-13
   PubMed 17389579
2. Hoel TN, Videm V, Mollnes TE, Saatvedt K, Brosstad F, Fiane AE, Fosse E, Svennevig JL (2007)
   Off-pump cardiac surgery abolishes complement activation
   Perfusion, 22 (4), 251-6
   PubMed 18181513
3. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007)
   Complement and coagulation: strangers or partners in crime?
   Trends Immunol, 28 (4), 184-92
   PubMed 17336159
4. Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodriguez de Cordoba S, Kirschfink M (2007)
   Complement analysis in the 21st century
   Mol Immunol, 44 (16), 3838-49
   PubMed 17768101
5. Nielsen EW, Waage C, Fure H, Brekke OL, Sfyroera G, Lambris JD, Mollnes TE (2007)
   Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement
   Mol Immunol, 44 (8), 1819-26
   PubMed 17101176
6. Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007)
   The role of complement in biomaterial-induced inflammation
   Mol Immunol, 44 (1-3), 82-94
   PubMed 16905192
7. Pedersen ED, Frøyland E, Kvissel AK, Pharo AM, Skålhegg BS, Rootwelt T, Mollnes TE (2007)
   Expression of complement regulators and receptors on human NT2-N neurons--effect of hypoxia and reoxygenation
   Mol Immunol, 44 (9), 2459-68
   PubMed 17116331
8. Pedersen ED, Aass HC, Rootwelt T, Fung M, Lambris JD, Mollnes TE (2007)
   CD59 efficiently protects human NT2-N neurons against complement-mediated damage
   Scand J Immunol, 66 (2-3), 345-51
   PubMed 17635812
9. Roestenberg M, McCall M, Mollnes TE, van Deuren M, Sprong T, Klasen I, Hermsen CC, Sauerwein RW, van der Ven A (2007)
   Complement activation in experimental human malaria infection
   Trans R Soc Trop Med Hyg, 101 (7), 643-9
   PubMed 17481680
10. Saethre M, Baumann BC, Fung M, Seebach JD, Mollnes TE (2007)
    Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells
    Transplantation, 84 (2), 244-50
    PubMed 17667817
11. Sikkeland LI, Thorgersen EB, Haug T, Mollnes TE (2007)
    Complement activation and cytokine response by BioProtein, a bacterial single cell protein
    Clin Exp Immunol, 148 (1), 146-52
    PubMed 17302729
12. Thorgersen EB, Ghebremariam YT, Thurman JM, Fung M, Nielsen EW, Holers VM, Kotwal GJ, Mollnes TE (2007)
    Candidate inhibitors of porcine complement
    Mol Immunol, 44 (8), 1827-34
    PubMed 17109963
13. Ødegård A, Aasland J, Myhre HO, Mollnes TE, Videm V (2007)
    The inflammatory response to stent grafting of the thoracic aorta
    Int Angiol, 26 (3), 219-27
    PubMed 17622202

Publications 2006

1. Drogset JO, Grøntvedt T, Jessen V, Tegnander A, Mollnes TE, Bergh K (2006)
   Comparison of in vitro and in vivo complement activation by metal and bioabsorbable screws used in anterior cruciate ligament reconstruction
   Arthroscopy, 22 (5), 489-96
   PubMed 16651157
2. Frøyland E, Pedersen ED, Kvissel AK, Almaas R, Pharo A, Skålhegg BS, Mollnes TE, Rootwelt T (2006)
   Effect of acidosis on IL-8 and MCP-1 during hypoxia and reoxygenation in human NT2-N neurons
   Brain Res, 1113 (1), 64-73
   PubMed 16919250
3. Harboe M, Garred P, Borgen MS, Stahl GL, Roos A, Mollnes TE (2006)
   Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions
   Clin Exp Immunol, 144 (3), 512-20
   PubMed 16734621
4. Mollnes TE, Kirschfink M (2006)
   Strategies of therapeutic complement inhibition
   Mol Immunol, 43 (1-2), 107-21
   PubMed 16011851
5. Mollnes TE, Kirschfink M (2006)
   Complement analysis in clinic and research
   Adv Exp Med Biol, 586, 361-80
   PubMed 16893084
6. Saethre M, Lea T, Borgen MS, Fiane AE, Michaelsen TE, Thorsby E, Haraldsen G, Mollnes TE (2006)
   Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation
   Xenotransplantation, 13 (3), 215-23
   PubMed 16756564
7. Sprong T, Roos D, Weemaes C, Neeleman C, Geesing CL, Mollnes TE, van Deuren M (2006)
   Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections
   Blood, 107 (12), 4865-70
   PubMed 16527897
8. Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P (2006)
   Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
   J Card Fail, 12 (8), 659-63
   PubMed 17045187
9. Waelgaard L, Pharo A, Tønnessen TI, Mollnes TE (2006)
   Microdialysis for monitoring inflammation: efficient recovery of cytokines and anaphylotoxins provided optimal catheter pore size and fluid velocity conditions
   Scand J Immunol, 64 (3), 345-52
   PubMed 16918704

Publications 2005

1. Castellheim A, Lindenskov PH, Pharo A, Aamodt G, Saugstad OD, Mollnes TE (2005)
   Meconium aspiration syndrome induces complement-associated systemic inflammatory response in newborn piglets
   Scand J Immunol, 61 (3), 217-25
   PubMed 15787738
2. Castellheim A, Pharo A, Fung M, Saugstad OD, Mollnes TE (2005)
   Complement C5a is a key mediator of meconium-induced neutrophil activation
   Pediatr Res, 57 (2), 242-7
   PubMed 15585680
3. Fevang B, Mollnes TE, Holm AM, Ueland T, Heggelund L, Damås JK, Aukrust P, Frøland SS (2005)
   Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis
   Clin Exp Immunol, 142 (3), 576-84
   PubMed 16297171
4. Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE (2005)
   Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
   Eur Heart J, 26 (16), 1660-5
   PubMed 15821010
5. Heggelund L, Mollnes TE, Espevik T, Müller F, Kristiansen KI, Aukrust P, Frøland SS (2005)
   Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection
   Eur J Clin Invest, 35 (12), 765-70
   PubMed 16313253
6. Hognestad A, Endresen K, Wergeland R, Mellembakken JR, Mollnes TE, Omland T, Kjekshus JK, Aukrust P, Andreassen AK (2005)
   Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis
   J Heart Lung Transplant, 24 (8), 1026-32
   PubMed 16102437
7. Lappegård KT, Bergseth G, Riesenfeld J, Sexton J, Mollnes TE (2005)
   Role of granulocytes and monocytes in the polyvinyl chloride-induced synthesis of interleukin 8, monocyte chemoattractant protein 1, and leukotriene B4
   J Biomed Mater Res A, 74 (2), 230-6
   PubMed 15962266
8. Lappegård KT, Riesenfeld J, Brekke OL, Bergseth G, Lambris JD, Mollnes TE (2005)
   Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production
   Ann Thorac Surg, 79 (3), 917-23
   PubMed 15734405
9. Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjöholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR (2005)
   Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA
   J Immunol Methods, 296 (1-2), 187-98
   PubMed 15680163
10. Sørlie D, Wisborg T, Wählby L, Wilskow A, Mollnes TE, Gamnes J, Arnesen E (2005)
    [A programme for boosting medical research in North Norway, 1992-2001]
    Tidsskr Nor Laegeforen, 125 (4), 449-50
    PubMed 15742020
11. Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2005)
    Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome
    Scand J Clin Lab Invest, 65 (4), 283-90
    PubMed 16076683

Publications 2004

1. Bossi F, Fischetti F, Pellis V, Bulla R, Ferrero E, Mollnes TE, Regoli D, Tedesco F (2004)
   Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex
   J Immunol, 173 (11), 6921-7
   PubMed 15557188
2. Castellheim A, Lindenskov PH, Pharo A, Fung M, Saugstad OD, Mollnes TE (2004)
   Meconium is a potent activator of complement in human serum and in piglets
   Pediatr Res, 55 (2), 310-8
   PubMed 14605246
3. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE (2004)
   The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation
   Clin Exp Immunol, 138 (3), 439-46
   PubMed 15544620
4. Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, Aukrust P, Espevik T, Frøland SS (2004)
   Soluble toll-like receptor 2 in HIV infection: association with disease progression
   AIDS, 18 (18), 2437-9
   PubMed 15622324
5. Hoel TN, Videm V, Baksaas ST, Mollnes TE, Brosstad F, Svennevig JL (2004)
   Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery
   Perfusion, 19 (3), 177-84
   PubMed 15298426
6. Lappegård KT, Fung M, Bergseth G, Riesenfeld J, Lambris JD, Videm V, Mollnes TE (2004)
   Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation
   Ann Thorac Surg, 77 (3), 932-41
   PubMed 14992902
7. Lappegård KT, Fung M, Bergseth G, Riesenfeld J, Mollnes TE (2004)
   Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition
   Ann Thorac Surg, 78 (1), 38-44; discussion 44-5
   PubMed 15223398
8. Lappegård KT, Hvassing T, Mollnes TE (2004)
   Statin drugs do not affect serum complement activation in vitro
   Scand J Immunol, 60 (1-2), 178-83
   PubMed 15238087
9. Lindenskov PH, Castellheim A, Aamodt G, Saugstad OD, Mollnes TE (2004)
   Complement activation reflects severity of meconium aspiration syndrome in newborn pigs
   Pediatr Res, 56 (5), 810-7
   PubMed 15347770
10. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE (2004)
    Systemic complement activation following human acute ischaemic stroke
    Clin Exp Immunol, 137 (1), 117-22
    PubMed 15196251
11. Sprong T, Møller AS, Bjerre A, Wedege E, Kierulf P, van der Meer JW, Brandtzaeg P, van Deuren M, Mollnes TE (2004)
    Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide
    Infect Immun, 72 (6), 3344-9
    PubMed 15155639
12. Sund S, Reisaeter AV, Scott H, Mollnes TE, Hovig T (2004)
    Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies
    Clin Nephrol, 62 (2), 121-30
    PubMed 15356969
13. Trøseid M, Lappegård KT, Claudi T, Damås JK, Mørkrid L, Brendberg R, Mollnes TE (2004)
    Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome
    Eur Heart J, 25 (4), 349-55
    PubMed 14984925

Publications 2003

1. Fiane AE, Videm V, Lingaas PS, Heggelund L, Nielsen EW, Geiran OR, Fung M, Mollnes TE (2003)
   Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair
   Circulation, 108 (7), 849-56
   PubMed 12900342
2. Fung M, Lu M, Fure H, Sun W, Sun C, Shi NY, Dou Y, Su J, Swanson X, Mollnes TE (2003)
   Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage
   Clin Exp Immunol, 133 (2), 160-9
   PubMed 12869020
3. Heggelund L, Mollnes TE, Ueland T, Christophersen B, Aukrust P, Frøland SS (2003)
   Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy
   J Acquir Immune Defic Syndr, 32 (4), 354-61
   PubMed 12640191
4. Kirschfink M, Mollnes TE (2003)
   Modern complement analysis
   Clin Diagn Lab Immunol, 10 (6), 982-9
   PubMed 14607856
5. Mollnes TE (2003)
   Measurement of complement activation
   Methods Mol Biol, 225, 69-75
   PubMed 12769475
6. Mollnes TE, Fiane AE (2003)
   Perspectives on complement in xenotransplantation
   Mol Immunol, 40 (2-4), 135-43
   PubMed 12914819
7. Risnes I, Ueland T, Aukrust P, Lundblad R, Baksaas ST, Mollnes TE, Svennevig JL (2003)
   Complement activation and cytokine and chemokines release during mediastinitis
   Ann Thorac Surg, 75 (3), 981-5
   PubMed 12645727
8. Risnes I, Ueland T, Lundblad R, Mollnes TE, Baksaas ST, Aukrust P, Svennevig JL (2003)
   Changes in the cytokine network and complement parameters during open heart surgery
   Interact Cardiovasc Thorac Surg, 2 (1), 19-24
   PubMed 17669979
9. Solheim BG, Flesland O, Brosstad F, Mollnes TE, Seghatchian J (2003)
   Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood
   Transfus Apher Sci, 29 (2), 133-9
   PubMed 12941351
10. Sprong T, Brandtzaeg P, Fung M, Pharo AM, Høiby EA, Michaelsen TE, Aase A, van der Meer JW, van Deuren M, Mollnes TE (2003)
    Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis
    Blood, 102 (10), 3702-10
    PubMed 12881318
11. Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal Ø, Mollnes TE (2003)
    Complement activation in early protocol kidney graft biopsies after living-donor transplantation
    Transplantation, 75 (8), 1204-13
    PubMed 12717204
12. Tølløfsrud S, Noddeland H, Svennevig JL, Bentsen G, Mollnes TE, Solheim BG (2003)
    Universal fresh frozen plasma (Uniplas): a safe product in open-heart surgery
    Intensive Care Med, 29 (10), 1736-43
    PubMed 12955185

Publications 2002

1. Bjerre A, Brusletto B, Mollnes TE, Fritzsønn E, Rosenqvist E, Wedege E, Namork E, Kierulf P, Brandtzaeg P (2002)
   Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant
   J Infect Dis, 185 (2), 220-8
   PubMed 11807696
2. Evgenov OV, Evgenov NV, Mollnes TE, Bjertnaes LJ (2002)
   Methylene blue reduces pulmonary oedema and cyclo-oxygenase products in endotoxaemic sheep
   Eur Respir J, 20 (4), 957-64
   PubMed 12412689
3. Fiane AE, Geiran OR, Mollnes TE (2002)
   [Ethical aspects of xenotransplantation]
   Tidsskr Nor Laegeforen, 122 (4), 397-400
   PubMed 11915670
4. Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, Bergseth G, Videm V, Lappegård KT, Köhl J, Lambris JD (2002)
   Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation
   Blood, 100 (5), 1869-77
   PubMed 12176911
5. Mollnes TE, Fiane AE (2002)
   Role of complement in xenotransplantation
   Allergy, 57 Suppl 72, 75-8
   PubMed 12144560
6. Mollnes TE, Song WC, Lambris JD (2002)
   Complement in inflammatory tissue damage and disease
   Trends Immunol, 23 (2), 61-4
   PubMed 11929126
7. Nielsen EW, Mollnes TE, Harlan JM, Winn RK (2002)
   C1-inhibitor reduces the ischaemia-reperfusion injury of skeletal muscles in mice after aortic cross-clamping
   Scand J Immunol, 56 (6), 588-92
   PubMed 12472670
8. Saethre M, Sølvik UØ, Haraldsen G, Fiane AE, Boretti E, Thorsby E, Platt JL, Mollnes TE (2002)
   Human serum-induced porcine endothelial cell E-selectin expression is associated with IgG3 and IgM anti-Gal antibodies
   Xenotransplantation, 9 (5), 350-8
   PubMed 12199866
9. Scholz T, Solberg R, Okkenhaug C, Videm V, Gallimore MJ, Mathisen O, Mollnes TE, Bergan A, Søreide O, Klintmalm GB, Aasen AO (2002)
   The significance of heparin-coated veno-venous bypass circuits in liver transplantation
   Perfusion, 17 (1), 45-50
   PubMed 11817529

Publications 2001

1. Aukrust P, Gullestad L, Lappegård KT, Ueland T, Aass H, Wikeby L, Simonsen S, Frøland SS, Mollnes TE (2001)
   Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment
   Circulation, 104 (13), 1494-500
   PubMed 11571242
2. Kirschfink M, Mollnes TE (2001)
   C1-inhibitor: an anti-inflammatory reagent with therapeutic potential
   Expert Opin Pharmacother, 2 (7), 1073-83
   PubMed 11583058
3. Lamark T, Ingebrigtsen M, Bjørnstad C, Melkko T, Mollnes TE, Nielsen EW (2001)
   Expression of active human C1 inhibitor serpin domain in Escherichia coli
   Protein Expr Purif, 22 (2), 349-58
   PubMed 11437612
4. Mellembakken JR, Høgåsen K, Mollnes TE, Hack CE, Abyholm T, Videm V (2001)
   Increased systemic activation of neutrophils but not complement in preeclampsia
   Obstet Gynecol, 97 (3), 371-4
   PubMed 11239639
5. Scholz T, Solberg R, Okkenhaug C, Videm V, Gallimore MJ, Mathisen O, Pedersen T, Mollnes TE, Bergan A, Søreide O, Klintmalm GB, Aasen AO (2001)
   Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model
   Perfusion, 16 (4), 285-92
   PubMed 11486847
6. Sølvik UO, Haraldsen G, Fiane AE, Boretti E, Thorsby E, Mollnes TE (2001)
   C1-inhibitor attenuates human serum induced E-selectin expression of pig aortic endothelial cells
   Transplant Proc, 33 (1-2), 789-90
   PubMed 11267073
7. Sølvik UØ, Haraldsen G, Fiane AE, Boretti E, Lambris JD, Fung M, Thorsby E, Mollnes TE (2001)
   Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated
   Transplantation, 72 (12), 1967-73
   PubMed 11773897
8. Ulvestad E, Berentsen S, Mollnes TE (2001)
   Acute phase haemolysis in chronic cold agglutinin disease
   Scand J Immunol, 54 (1-2), 239-42
   PubMed 11439172

Publications 2000

1. Bergseth G, Lappegård KT, Videm V, Mollnes TE (2000)
   A novel enzyme immunoassay for plasma thrombospondin. Comparison with beta-thromboglobulin as platelet activation marker in vitro and in vivo
   Thromb Res, 99 (1), 41-50
   PubMed 10904102
2. Fiane AE, Mollnes TE, Degré M (2000)
   Pig endogenous retrovirus--a threat to clinical xenotransplantation?
   APMIS, 108 (4), 241-50
   PubMed 10843410
3. Fiane AE, Videm V, Lambris JD, Geiran OR, Svennevig JL, Mollnes TE (2000)
   Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model
   Transplant Proc, 32 (5), 899-900
   PubMed 10936264
4. Myhr KM, Sadallah S, Mollnes TE, Meri S, Nyland HI, Schifferli J, Vedeler CA (2000)
   Interferon-alpha2a effects on complement activation and regulation in MS patients
   Acta Neurol Scand, 101 (1), 30-5
   PubMed 10660149
5. Odegård A, Lundbom J, Myhre HO, Hatlinghus S, Bergh K, Waage A, Bjerve KS, Mollnes TE, Aadahl P, Lie TA, Videm V (2000)
   The inflammatory response following treatment of abdominal aortic aneurysms: a comparison between open surgery and endovascular repair
   Eur J Vasc Endovasc Surg, 19 (5), 536-44
   PubMed 10828237
6. Olsson P, Sanchez J, Mollnes TE, Riesenfeld J (2000)
   On the blood compatibility of end-point immobilized heparin
   J Biomater Sci Polym Ed, 11 (11), 1261-73
   PubMed 11263812

Publications 1999

1. Baksaas ST, Flom-Halvorsen HI, Ovrum E, Videm V, Mollnes TE, Brosstad F, Svennevig JL (1999)
   Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery
   Perfusion, 14 (2), 107-17
   PubMed 10338322
2. Baksaas ST, Videm V, Fosse E, Karlsen H, Pedersen T, Mollnes TE, Hagve TA, Svennevig JL (1999)
   In vitro evaluation of new surface coatings for extracorporeal circulation
   Perfusion, 14 (1), 11-9
   PubMed 10074642
3. Baksaas ST, Videm V, Pedersen T, Karlsen H, Mollnes TE, Brosstad F, Svennevig JL (1999)
   Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices
   Perfusion, 14 (2), 119-27
   PubMed 10338323
4. Fiane AE, Mollnes TE (1999)
   [Transplantation from animal to man]
   Tidsskr Nor Laegeforen, 119 (28), 4213-8
   PubMed 10668386
5. Fiane AE, Mollnes TE, Videm V, Hovig T, Høgåsen K, Mellbye OJ, Spruce L, Moore WT, Sahu A, Lambris JD (1999)
   Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor Compstatin
   Transplant Proc, 31 (1-2), 934-5
   PubMed 10083413
6. Fiane AE, Mollnes TE, Videm V, Hovig T, Høgåsen K, Mellbye OJ, Spruce L, Moore WT, Sahu A, Lambris JD (1999)
   Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts
   Xenotransplantation, 6 (1), 52-65
   PubMed 10355733
7. Fiane AE, Videm V, Johansen HT, Mellbye OJ, Nielsen EW, Mollnes TE (1999)
   C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model
   Immunopharmacology, 42 (1-3), 231-43
   PubMed 10408384
8. Fiane AE, Videm V, Mollnes TE, Høgâsen K, Hovig T (1999)
   Inhibition of platelet aggregation by the GPIIb/IIIa antagonist reopro does not significantly prolong xenograft survival in an ex vivo model
   Transpl Int, 12 (5), 323-33
   PubMed 10551997
9. Krohn CD, Reikerås O, Mollnes TE (1999)
   Complement activation and increased systemic and pulmonary vascular resistance indices during infusion of postoperatively drained untreated blood
   Br J Anaesth, 82 (1), 47-51
   PubMed 10325835
10. Mollnes TE, Fiane AE (1999)
    Xenotransplantation: how to overcome the complement obstacle?
    Mol Immunol, 36 (4-5), 269-76
    PubMed 10403480
11. Mollnes TE, Haga HJ, Brun JG, Nielsen EW, Sjöholm A, Sturfeldt G, Mårtensson U, Bergh K, Rekvig OP (1999)
    Complement activation in patients with systemic lupus erythematosus without nephritis
    Rheumatology (Oxford), 38 (10), 933-40
    PubMed 10534542
12. Mollnes TE, Videm V, Christiansen D, Bergseth G, Riesenfeld J, Hovig T (1999)
    Platelet compatibility of an artificial surface modified with functionally active heparin
    Thromb Haemost, 82 (3), 1132-6
    PubMed 10494777
13. Neeleman C, Geelen SP, Aerts PC, Daha MR, Mollnes TE, Roord JJ, Posthuma G, van Dijk H, Fleer A (1999)
    Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H
    Infect Immun, 67 (9), 4517-24
    PubMed 10456894
14. Videm V, Mollnes TE, Bergh K, Fosse E, Mohr B, Hagve TA, Aasen AO, Svennevig JL (1999)
    Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo
    J Thorac Cardiovasc Surg, 117 (4), 803-9
    PubMed 10096977
15. Videm V, Mollnes TE, Fosse E, Mohr B, Bergh K, Hagve TA, Aasen AO, Svennevig JL (1999)
    Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population
    J Thorac Cardiovasc Surg, 117 (4), 794-802
    PubMed 10096976

Publications 1998

1. Arnestad JP, Hyllner M, Bengtson JP, Tylman M, Mollnes TE, Bengtsson A (1998)
   Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration
   Acta Anaesthesiol Scand, 42 (7), 811-5
   PubMed 9698958
2. Baksaas ST, Videm V, Mollnes TE, Tølløfsrud S, Hetland G, Pedersen T, Svennevig JL (1998)
   Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets
   Perfusion, 13 (6), 429-36
   PubMed 9881390
3. Bengtsson A, Redl H, Schlag G, Högåsen K, Götze O, Mollnes TE (1998)
   Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation
   Scand J Immunol, 48 (5), 509-14
   PubMed 9822260
4. Fiane AE, Videm V, Foerster A, Scholz T, Perdersen TH, Karlsen H, Svennevig JL, Geiran OR, Aasen AO, Mollnes TE (1998)
   An ex vivo perfusion model to evaluate hyperacute rejection in a discordant pig-to-human combination
   Eur Surg Res, 30 (5), 341-51
   PubMed 9731103
5. Fiane AE, Videm V, Mellbye OJ, Foerster A, Geiran OR, Gladhaug IP, Svennevig JL, Mollnes TE (1998)
   Immunoglobulin prolongs survival of pig kidneys perfused ex vivo with human blood
   Scand J Immunol, 47 (6), 568-74
   PubMed 9652825
6. Fosse E, Pillgram-Larsen J, Svennevig JL, Nordby C, Skulberg A, Mollnes TE, Abdelnoor M (1998)
   Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma
   Injury, 29 (7), 509-14
   PubMed 10193492
7. Hetland G, Mollnes TE, Bergh K, Høgåsen K, Bergerud UE, Solheim BG (1998)
   Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4
   Transfusion, 38 (1), 16-23
   PubMed 9482389
8. Høgåsen K, Mollnes TE, Nürnberger W, Pausa M, Fukumori Y, Tedesco F (1998)
   Characterization of soluble terminal complement complex assembled in C8beta-deficient plasma and serum
   Scand J Immunol, 48 (3), 261-8
   PubMed 9743210
9. Krohn CD, Reikerås O, Mollnes TE, Aasen AO (1998)
   Complement activation and release of interleukin-6 and tumour necrosis factor-alpha in drained and systemic blood after major orthopaedic surgery
   Eur J Surg, 164 (2), 103-8
   PubMed 9537716
10. Mollnes TE (1998)
    Complement and biocompatibility
    Vox Sang, 74 Suppl 2, 303-7
    PubMed 9704460
11. Mollnes TE, Høgåsen K, De Carolis C, Vaquero E, Nielsen EW, Fontana L, Perricone R (1998)
    High-dose intravenous immunoglobulin treatment activates complement in vivo
    Scand J Immunol, 48 (3), 312-7
    PubMed 9743219
12. Nielsen EW, Fure H, Winge P, Mollnes TE (1998)
    Identification of a C-->T mutation in the reactive-site coding region of the C1-inhibitor gene and its detection by an improved mutation-specific polymerase chain reaction method
    Scand J Immunol, 47 (3), 273-6
    PubMed 9519866
13. Nordang L, Laurent C, Mollnes TE (1998)
    Complement activation in sudden deafness
    Arch Otolaryngol Head Neck Surg, 124 (6), 633-6
    PubMed 9639471
14. Solheim BG, Bergerud UE, Kjeldsen-Kragh J, Brosstad F, Mollnes TE, Högman CF, Eriksson L, Schutz R (1998)
    Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood
    Vox Sang, 74 (3), 168-75
    PubMed 9595644

Publications 1997

1. Baksaas ST, Videm V, Mollnes TE, Pedersen T, Karlsen H, Svennevig JL (1997)
   Effects on complement, granulocytes and platelets of a leukocyte-depletion filter during in vitro extracorporeal circulation
   Scand Cardiovasc J, 31 (2), 73-7
   PubMed 9211593
2. Fosse E, Thelin S, Svennevig JL, Jansen P, Mollnes TE, Hack E, Venge P, Moen O, Brockmeier V, Dregelid E, Haldén E, Hagman L, Videm V, Pedersen T, Mohr B (1997)
   Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study
   Eur J Cardiothorac Surg, 11 (2), 320-7
   PubMed 9080162
3. Fure H, Nielsen EW, Hack CE, Mollnes TE (1997)
   A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s
   Scand J Immunol, 46 (6), 553-7
   PubMed 9420617
4. Garred P, Mollnes TE (1997)
   Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules
   Artif Organs, 21 (4), 293-9
   PubMed 9096801
5. Hetland G, Moen O, Bergh K, Högäsen K, Hack CE, Mollnes TE, Fosse E (1997)
   Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo
   Ann Thorac Surg, 63 (4), 1076-80
   PubMed 9124908
6. Homann C, Varming K, Høgåsen K, Mollnes TE, Graudal N, Thomsen AC, Garred P (1997)
   Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality
   Gut, 40 (4), 544-9
   PubMed 9176087
7. Moen O, Høgåsen K, Fosse E, Dregelid E, Brockmeier V, Venge P, Harboe M, Mollnes TE (1997)
   Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass
   Ann Thorac Surg, 63 (1), 105-11
   PubMed 8993250
8. Mollnes TE (1997)
   Biocompatibility: complement as mediator of tissue damage and as indicator of incompatibility
   Exp Clin Immunogenet, 14 (1), 24-9
   PubMed 9187920
9. Mollnes TE, Andreassen IH, Høgåsen K, Hack CE, Harboe M (1997)
   Effect of whole and fractionated intravenous immunoglobulin on complement in vitro
   Mol Immunol, 34 (10), 719-29
   PubMed 9430199
10. Pedersen TH, Videm V, Svennevig JL, Karlsen H, Ostbakk RW, Jensen O, Mollnes TE (1997)
    Extracorporeal membrane oxygenation using a centrifugal pump and a servo regulator to prevent negative inlet pressure
    Ann Thorac Surg, 63 (5), 1333-9
    PubMed 9146324
11. Samdal F, Mollnes TE, Amland PF, Truedsson L (1997)
    Modest release of adipsin/factor D by liposuction when using the superwet or tumescent technique
    Plast Reconstr Surg, 99 (6), 1591-4; discussion 1595-6
    PubMed 9145127

Publications 1996

1. Bengtsson A, Redl H, Schlag G, Mollnes TE, Högåsen K (1996)
   Effects on complement activation and cytokine (TNF-alpha and IL-8) release of infusion of anti-TNF-antibodies or a xanthine derivative (HWA 138) in septic baboons
   Acta Anaesthesiol Scand, 40 (2), 244-9
   PubMed 8848926
2. Brandtzaeg P, Høgåsen K, Kierulf P, Mollnes TE (1996)
   The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation
   J Infect Dis, 173 (3), 647-55
   PubMed 8627028
3. Bringeland EA, Ramstad K, Nielsen EW, Andersen L, Amundsen W, Mollnes TE (1996)
   [Reduced blood utilization in hip arthroplasty. Introduction of a blood preservation program]
   Tidsskr Nor Laegeforen, 116 (1), 30-3
   PubMed 8553331
4. Gong J, Larsson R, Ekdahl KN, Mollnes TE, Nilsson U, Nilsson B (1996)
   Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model
   J Clin Immunol, 16 (4), 222-9
   PubMed 8840224
5. Høgåsen K, Homann C, Mollnes TE, Graudal N, Høgåsen AK, Hasselqvist P, Thomsen AC, Garred P (1996)
   Serum clusterin and vitronectin in alcoholic cirrhosis
   Liver, 16 (2), 140-6
   PubMed 8740849
6. Mellbye OJ, Shen Y, Høgåsen K, Mollnes TE, Førre O (1996)
   Adhesion molecule expression and complement activation in vessel walls in synovial tissue from patients with chronic inflammatory joint disease
   Clin Rheumatol, 15 (5), 441-7
   PubMed 8894356
7. Moen O, Fosse E, Bråten J, Andersson C, Høgåsen K, Mollnes TE, Venge P, Kierulf P (1996)
   Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit
   Perfusion, 11 (2), 113-23
   PubMed 8740352
8. Moen O, Fosse E, Dregelid E, Brockmeier V, Andersson C, Høgåsen K, Venge P, Mollnes TE, Kierulf P (1996)
   Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility
   Ann Thorac Surg, 62 (4), 1134-40
   PubMed 8823102
9. Mollnes TE, Harboe M (1996)
   Clinical immunology
   BMJ, 312 (7044), 1465-9
   PubMed 8664630
10. Nielsen EW, Gran JT, Straume B, Mellbye OJ, Johansen HT, Mollnes TE (1996)
    Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses
    J Intern Med, 239 (2), 119-30
    PubMed 8568479
11. Nielsen EW, Johansen HT, Høgåsen K, Wuillemin W, Hack CE, Mollnes TE (1996)
    Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema
    Scand J Immunol, 44 (2), 185-92
    PubMed 8711433
12. Nielsen EW, Johansen HT, Høgåsen K, Wuillemin W, Hack CE, Mollnes TE (1996)
    Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema
    Immunopharmacology, 33 (1-3), 359-60
    PubMed 8856186
13. Ovrum E, Fosse E, Mollnes TE, Am Holen E, Tangen G, Abdelnoor M, Ringdal MA, Oystese R, Venge P (1996)
    Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation
    Eur J Cardiothorac Surg, 10 (1), 54-60
    PubMed 8776186
14. Radillo O, Nocera A, Leprini A, Barocci S, Mollnes TE, Pocecco M, Pausa M, Valente U, Betterle C, Tedesco F (1996)
    Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic
    Clin Immunol Immunopathol, 79 (3), 217-23
    PubMed 8635278
15. Svennevig JL, Tølløfsrud S, Kongsgaard U, Noddeland H, Mohr B, Ozer M, Mollnes TE (1996)
    Complement activation during and after open-heart surgery is only marginally affected by the choice of fluid for volume replacement
    Perfusion, 11 (4), 326-32
    PubMed 8884861
16. Saatvedt K, Lindberg H, Geiran OR, Michelsen S, Pedersen T, Seem E, Mollnes TE (1996)
    Ultrafiltration after cardiopulmonary bypass in children: effects on hemodynamics, cytokines and complement
    Cardiovasc Res, 31 (4), 596-602
    PubMed 8689651
17. Saatvedt K, Lindberg H, Michelsen S, Mollnes TE (1996)
    Release of interleukin 6 and activation of complement during and after paediatric cardiopulmonary bypass. Effect of autotransfusion of shed mediastinal blood and ultrafiltration
    Cytokine, 8 (5), 417-20
    PubMed 8726671

Publications 1995

1. Abrahamsen TG, Mollnes TE, Vandvik B (1995)
   Intrathecal immune response in neonatal Flavobacterium meningosepticum meningitis
   Biol Neonate, 68 (2), 153-6
   PubMed 8534775
2. Fiane AE, Videm V, Scholz T, Pedersen T, Karlsen H, Geiran O, Foerster A, Mollnes T, Aasen AO, Svennevig J (1995)
   Ex vivo model for xenotransplantation
   Transplant Proc, 27 (6), 3560-1
   PubMed 8540102
3. Høgåsen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M (1995)
   Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency
   J Clin Invest, 95 (3), 1054-61
   PubMed 7883953
4. Høgåsen K, Mollnes TE, Harboe M, Götze O, Hammer HB, Oppermann M (1995)
   Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid
   J Rheumatol, 22 (1), 24-8
   PubMed 7535360
5. Kjeldsen-Kragh J, Mellbye OJ, Haugen M, Mollnes TE, Hammer HB, Sioud M, Førre O (1995)
   Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet
   Scand J Rheumatol, 24 (2), 85-93
   PubMed 7747149
6. Kuroki K, Roy S, Laerum F, Mollnes TE, Solheim BG, Videm V (1995)
   Complement activation by angiographic catheters in vitro
   J Vasc Interv Radiol, 6 (5), 819-26
   PubMed 8541691
7. Moen O, Fosse E, Brockmeier V, Andersson C, Mollnes TE, Høgåsen K, Venge P (1995)
   Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems
   Ann Thorac Surg, 60 (5), 1317-23
   PubMed 8526620
8. Mollnes TE, Høgåsen K, Hoaas BF, Michaelsen TE, Garred P, Harboe M (1995)
   Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties
   Scand J Immunol, 41 (5), 449-56
   PubMed 7725063
9. Mollnes TE, Riesenfeld J, Garred P, Nordström E, Høgåsen K, Fosse E, Götze O, Harboe M (1995)
   A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin
   Artif Organs, 19 (9), 909-17
   PubMed 8687297
10. Nielsen EW, Johansen HT, Gaudesen O, Osterud B, Olsen JO, Høgåsen K, Hack CE, Mollnes TE (1995)
    C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients
    Scand J Immunol, 42 (6), 679-85
    PubMed 8552992
11. Ovrum E, Mollnes TE, Fosse E, Holen EA, Tangen G, Abdelnoor M, Ringdal MA, Oystese R, Venge P (1995)
    Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
    J Thorac Cardiovasc Surg, 110 (6), 1623-32
    PubMed 8523872
12. Ovrum E, Mollnes TE, Fosse E, Holen EA, Tangen G, Ringdal MA, Videm V (1995)
    High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes
    Ann Thorac Surg, 60 (6), 1755-61
    PubMed 8787476
13. Riesenfeld J, Olsson P, Sanchez J, Mollnes TE (1995)
    Surface modification with functionally active heparin
    Med Device Technol, 6 (2), 24-31
    PubMed 10155375
14. Røger M, Høgåsen K, Holme PA, Halstensen TS, Mollnes TE, Hovig T (1995)
    The Fluid-phase SC5b-9 Terminal Complement Complex Binds to the GPIIb/IIIa Complex of Thrombin-stimulated Human Blood Platelets Inhibiting Platelet Aggregation
    Platelets, 6 (3), 160-8
    PubMed 21043620
15. Samdal F, Aasen AO, Mollnes TE, Høgåsen K, Amland PF (1995)
    Effect of syringe-assisted liposuction on activation of cascade systems and circulating cells when using the superwet or tumescent technique
    Ann Plast Surg, 35 (3), 242-8
    PubMed 7503516
16. Saatvedt K, Lindberg H, Geiran OR, Michelsen S, Aasen AO, Pedersen T, Mollnes TE (1995)
    Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children
    Scand J Clin Lab Invest, 55 (1), 79-86
    PubMed 7624740

Publications 1994

1. Busund R, Rønning G, Lindsetmo RO, Busund LT, Mollnes TE, Konopski Z, Revhaug A (1994)
   The effects of plasma and albumin infusion on organ function and sepsis markers in experimental gram-negative sepsis
   Shock, 2 (6), 402-7
   PubMed 7743369
2. Fosse E, Moen O, Johnson E, Semb G, Brockmeier V, Mollnes TE, Fagerhol MK, Venge P (1994)
   Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass
   Ann Thorac Surg, 58 (2), 472-7
   PubMed 8067851
3. Høgåsen K, Mollnes TE, Brandtzaeg P (1994)
   Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex
   Infect Immun, 62 (11), 4874-80
   PubMed 7523299
4. Mellbye OJ, Mollnes TE, Steen LS (1994)
   IgG subclass distribution and complement activation ability of autoantibodies to neutrophil cytoplasmic antigens (ANCA)
   Clin Immunol Immunopathol, 70 (1), 32-9
   PubMed 8261667
5. Moen O, Fosse E, Bråten J, Andersson C, Fagerhol MK, Venge P, Høgåsen K, Mollnes TE (1994)
   Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation
   Perfusion, 9 (2), 109-17
   PubMed 7919596
6. Mollnes TE, Fosse E (1994)
   The complement system in trauma-related and ischemic tissue damage: a brief review
   Shock, 2 (4), 301-10
   PubMed 7757525
7. Nielsen EW, Johansen HT, Holt J, Mollnes TE (1994)
   C1 inhibitor and diagnosis of hereditary angioedema in newborns
   Pediatr Res, 35 (2), 184-7
   PubMed 8165053
8. Nielsen EW, Johansen HT, Straume B, Mollnes TE (1994)
   Effect of time, temperature and additives on a functional assay of C1 inhibitor
   J Immunol Methods, 173 (2), 245-51
   PubMed 8046257
9. Nielsen EW, Stenberg PA, Einarsen E, Johansen HT, Mollnes TE (1994)
   [Angioedema associated with ACE inhibitors]
   Tidsskr Nor Laegeforen, 114 (7), 804-6
   PubMed 8009499
10. Røger M, Høgåsen K, Mollnes TE, Hovig T (1994)
    The Membrane Glycoprotein IIb/IIIa Complex Mediates Deposition of Thrombin-stimulated Blood Platelets on Polystyrene Plastic Under Static Conditions
    Platelets, 5 (2), 96-104
    PubMed 21043610
11. Verduin CM, Jansze M, Hol C, Mollnes TE, Verhoef J, van Dijk H (1994)
    Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation
    Infect Immun, 62 (2), 589-95
    PubMed 8300216
12. Videm V, Mollnes TE (1994)
    Human complement activation by polygeline and dextran 70
    Scand J Immunol, 39 (3), 314-20
    PubMed 7510416

Publications 1993

1. Bengtsson A, Redl H, Paul E, Schlag G, Mollnes TE, Davies J (1993)
   Complement and leukocyte activation in septic baboons
   Circ Shock, 39 (2), 83-8
   PubMed 8490996
2. Garred P, Fosse E, Fagerhol MK, Videm V, Mollnes TE (1993)
   Calprotectin and complement activation during major operations with or without cardiopulmonary bypass
   Ann Thorac Surg, 55 (3), 694-9
   PubMed 8452432
3. Garred P, Lyon H, Christoffersen P, Mollnes TE, Tranum-Jensen J (1993)
   Deposition of C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis
   Liver, 13 (6), 305-10
   PubMed 7507546
4. Hetland G, Mollnes TE, Garred P (1993)
   The B chain, but not the A chain, of Ricinus communis activates human complement
   Cancer Lett, 75 (1), 59-63
   PubMed 8287382
5. Høgåsen K, Mollnes TE, Tschopp J, Harboe M (1993)
   Quantitation of vitronectin and clusterin. Pitfalls and solutions in enzyme immunoassays for adhesive proteins
   J Immunol Methods, 160 (1), 107-15
   PubMed 7680696
6. Jansen JH, Høgåsen K, Mollnes TE (1993)
   Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease)
   Am J Pathol, 143 (5), 1356-65
   PubMed 8238252
7. Jensen ET, Kharazmi A, Garred P, Kronborg G, Fomsgaard A, Mollnes TE, Høiby N (1993)
   Complement activation by Pseudomonas aeruginosa biofilms
   Microb Pathog, 15 (5), 377-88
   PubMed 8015418
8. Mollnes TE, Nielsen EW, Høgåsen K, Mellbye OJ (1993)
   [Complement analysis tests]
   Tidsskr Nor Laegeforen, 113 (2), 211-3
   PubMed 8430403
9. Mollnes TE, Redl H, Høgåsen K, Bengtsson A, Garred P, Speilberg L, Lea T, Oppermann M, Götze O, Schlag G (1993)
   Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC)
   Clin Exp Immunol, 91 (2), 295-300
   PubMed 7679061
10. Opdahl H, Mollnes TE, Naess O (1993)
    Effects of high dose E. coli lipopolysaccharide on rabbit lung function, and of subsequent addition of chemotactic granulocyte activators to their isolated, blood-perfused lungs
    Acta Anaesthesiol Scand, 37 (4), 334-42
    PubMed 8322560
11. Røger M, Høgåsen K, Solum NO, Mollnes TE, Hovig T (1993)
    Vitronectin inhibits blood platelet aggregation
    Platelets, 4 (4), 225-9
    PubMed 21043846
12. Svennevig JL, Geiran OR, Karlsen H, Pedersen T, Mollnes TE, Kongsgard U, Frøysaker T (1993)
    Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits
    J Thorac Cardiovasc Surg, 106 (3), 466-72
    PubMed 8361189

Publications 1992

1. Halstensen TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P (1992)
   Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis
   Gut, 33 (7), 902-8
   PubMed 1379568
2. Hetland G, Mollnes TE, Larsen J, Garred P (1992)
   Biocompatibility of white cell filters as evaluated by complement activation
   Transfusion, 32 (6), 557-61
   PubMed 1502709
3. Høgåsen K, Mollnes TE, Harboe M (1992)
   Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex
   J Biol Chem, 267 (32), 23076-82
   PubMed 1385412
4. Røger M, Halstensen TS, Høgåsen K, Mollnes TE, Solum NO, Hovig T (1992)
   Platelets and vitronectin: immunocytochemical localization and platelet interaction with exogenously added vitronectin
   Nouv Rev Fr Hematol, 34 (1), 47-54
   PubMed 1381819
5. Videm V, Fosse E, Mollnes TE, Garred P, Svennevig JL (1992)
   Time for new concepts about measurement of complement activation by cardiopulmonary bypass?
   Ann Thorac Surg, 54 (4), 725-31
   PubMed 1417231
6. Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE (1992)
   Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations
   J Thorac Cardiovasc Surg, 103 (4), 806-13
   PubMed 1548925

Publications 1991

1. Brandtzaeg P, Waage A, Mollnes TE, Oktedalen O, Kierulf P (1991)
   Severe human septic shock involves more than tumor necrosis factor
   Prog Clin Biol Res, 367, 25-42
   PubMed 1924430
2. Hetland G, Garred P, Mollnes TE, Størvold G (1991)
   The use of flow cytometry to detect the biosynthesis of complement components
   J Immunol Methods, 140 (2), 167-71
   PubMed 2066563
3. Hetland G, Mollnes TE, Garred P (1991)
   Activation of complement during apheresis
   Clin Exp Immunol, 84 (3), 535-8
   PubMed 1904328
4. Mellbye OJ, Førre O, Mollnes TE, Kvarnes L (1991)
   Immunopathology of subcutaneous rheumatoid nodules
   Ann Rheum Dis, 50 (12), 909-12
   PubMed 1768157
5. Mollnes TE, Videm V, Götze O, Harboe M, Oppermann M (1991)
   Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin
   Ann Thorac Surg, 52 (1), 92-7
   PubMed 2069469
6. Mollnes TE, Videm V, Riesenfeld J, Garred P, Svennevig JL, Fosse E, Hogasen K, Harboe M (1991)
   Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials
   Clin Exp Immunol, 86 Suppl 1, 21-6
   PubMed 1934602
7. Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E (1991)
   C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis
   Scand J Rheumatol, 20 (3), 183-9
   PubMed 2068540
8. Siemssen PA, Garred P, Olsen J, Aasen AO, Mollnes TE (1991)
   Activation of complement, kallikrein-kinin, fibrinolysis and coagulation systems by urinary catheters. Effect of time and temperature in biocompatibility studies
   Br J Urol, 67 (1), 83-7
   PubMed 1993281
9. Videm V, Mollnes TE, Garred P, Svennevig JL (1991)
   Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits
   J Thorac Cardiovasc Surg, 101 (4), 654-60
   PubMed 2008104

Publications 1990

1. Garred P, Hetland G, Mollnes TE, Stoervold G (1990)
   Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts
   Scand J Immunol, 32 (5), 555-60
   PubMed 2270435
2. Garred P, Michaelsen TE, Aase A, Mollnes TE (1990)
   C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes
   J Immunol, 144 (1), 198-203
   PubMed 2295791
3. Garred P, Mollnes TE, Thorsteinsson L, Erlendsson K, Steinsson K (1990)
   Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus
   Scand J Immunol, 31 (1), 59-64
   PubMed 2300790
4. Garred P, Våge DI, Mollnes TE, Harboe M (1990)
   Latex gloves as a cause of inflammation and eczema
   Lancet, 335 (8703), 1469
   PubMed 1972244
5. Halstensen TS, Mollnes TE, Garred P, Fausa O, Brandtzaeg P (1990)
   Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis
   Gastroenterology, 98 (5 Pt 1), 1264-71
   PubMed 1691118
6. Hetland G, Garred P, Pettersen HB, Mollnes TE, Johnson E (1990)
   S protein binds to serum-treated agarose beads independently of complement activation and the formation of the terminal complement complex on the beads
   Clin Exp Immunol, 79 (3), 459-62
   PubMed 1690618
7. Mellbye OJ, Vartdal F, Pahle J, Mollnes TE (1990)
   IgG and IgA subclass distribution of total immunoglobulin and rheumatoid factors in rheumatoid tissue plasma cells
   Scand J Rheumatol, 19 (5), 333-40
   PubMed 2218430
8. Monaco S, Bonetti B, Ferrari S, Moretto G, Nardelli E, Tedesco F, Mollnes TE, Nobile-Orazio E, Manfredini E, Bonazzi L (1990)
   Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy
   N Engl J Med, 322 (10), 649-52
   PubMed 1689461
9. Pettersen HB, Johnson E, Garred P, Hetland G, Osen SS, Mollnes TE (1990)
   Quantification of non-activated (native) complement component C9 synthesized by alveolar macrophages from patients with sarcoidosis
   Scand J Immunol, 31 (5), 657-63
   PubMed 2189215
10. Pettersen HB, Johnson E, Mollnes TE, Garred P, Hetland G, Osen SS (1990)
    Synthesis of complement by alveolar macrophages from patients with sarcoidosis
    Scand J Immunol, 31 (1), 15-23
    PubMed 1689072
11. Roeise O, Garred P, Mollnes TE, Stadaas JO, Aasen AO (1990)
    Methylprednisolone in high doses gives different effects on the early and the late part of complement
    Eur Surg Res, 22 (1), 41-9
    PubMed 2199200
12. Tedesco F, Radillo O, Candussi G, Nazzaro A, Mollnes TE, Pecorari D (1990)
    Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae
    Clin Exp Immunol, 80 (2), 236-40
    PubMed 2357851
13. Videm V, Fosse E, Mollnes TE, Garred P, Svennevig JL (1990)
    Complement activation with bubble and membrane oxygenators in aortocoronary bypass grafting
    Ann Thorac Surg, 50 (3), 387-91
    PubMed 2205161
14. Våge DI, Garred P, Lea T, Mollnes TE (1990)
    Elutable factors from latex-containing materials activate complement and inhibit cell proliferation. An in vitro biocompatibility study of medical devices
    Complement Inflamm, 7 (2), 63-70
    PubMed 2225794

Publications 1989

1. Brandtzaeg P, Mollnes TE, Kierulf P (1989)
   Complement activation and endotoxin levels in systemic meningococcal disease
   J Infect Dis, 160 (1), 58-65
   PubMed 2471750
2. Garred P, Mollnes TE, Kazatchkine MD (1989)
   Activation-dependent antigenic changes of human C3
   Complement Inflamm, 6 (3), 205-18
   PubMed 2472922
3. Garred P, Mollnes TE, Lea T, Lachmann PJ (1989)
   Enzyme immunoassay detection of circulating immune complexes by monoclonal antibodies to C3 neoepitopes with special reference to IgG concentration and to interfering anti-immunoglobulin antibodies
   J Immunol Methods, 117 (1), 59-66
   PubMed 2464039
4. Garred P, Olsen J, Mollnes TE, Bilde T, Glahn BE (1989)
   Biocompatibility of urinary catheters. Effect on complement activation
   Br J Urol, 63 (4), 367-71
   PubMed 2713618
5. Halstensen TS, Mollnes TE, Brandtzaeg P (1989)
   Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence
   Gastroenterology, 97 (1), 10-9
   PubMed 2498144
6. Halstensen TS, Mollnes TE, Fausa O, Brandtzaeg P (1989)
   Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon
   Gut, 30 (3), 361-6
   PubMed 2707635
7. Hetland G, Pettersen HB, Mollnes TE, Johnson E (1989)
   S-protein is synthesized by human monocytes and macrophages in vitro
   Scand J Immunol, 29 (1), 15-21
   PubMed 2466326
8. Høgevold HE, Aasen AO, Kierulf P, Garred P, Mollnes TE, Reikerås O (1989)
   High doses of corticosteroids in total hip replacement. Effects on components of coagulation, fibrinolytic, plasma kallikrein-kinin and complement systems
   Acta Chir Scand, 155 (4-5), 247-50
   PubMed 2678856
9. Kongsgaard UE, Smith-Erichsen N, Geiran O, Amundsen E, Mollnes TE, Garred P (1989)
   Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery
   Acta Anaesthesiol Scand, 33 (5), 343-7
   PubMed 2800971
10. Mollnes TE (1989)
    [The complement system--a fascinating biological cascade. 1--physiologic aspects]
    Tidsskr Nor Laegeforen, 109 (27), 2782-8
    PubMed 2815011
11. Mollnes TE (1989)
    [The complement system--a fascinating biological cascade. 2--clinical aspects]
    Tidsskr Nor Laegeforen, 109 (28), 2891-6
    PubMed 2815029
12. Mollnes TE (1989)
    Antigenic changes of complement components: relevance for the analysis of complement activation
    Complement Inflamm, 6 (3), 134-41
    PubMed 2472919
13. Mollnes TE, Abrahamsen TG, Garred P (1989)
    Alterations in the terminal complement pathway in leukopenic children with malignant diseases during episodes with evidence of infection
    Complement Inflamm, 6 (6), 460-9
    PubMed 2598645
14. Mollnes TE, Lea T, Tschopp J (1989)
    Activation-dependent epitopes in the terminal complement pathway
    Complement Inflamm, 6 (3), 223-35
    PubMed 2472924
15. Roeise O, Garred P, Mollnes TE, Aasen AO (1989)
    Studies on the dose dependence of endotoxin-induced in vitro activation of the complement system
    Eur Surg Res, 21 (1), 34-41
    PubMed 2714308
16. Videm V, Fosse E, Mollnes TE, Ellingsen O, Pedersen T, Karlsen H (1989)
    Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro
    J Thorac Cardiovasc Surg, 97 (5), 764-70
    PubMed 2709867

Publications 1988

1. Bhakdi S, Käflein R, Halstensen TS, Hugo F, Preissner KT, Mollnes TE (1988)
   Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes
   Clin Exp Immunol, 74 (3), 459-64
   PubMed 2466593
2. Brandtzaeg P, Kierulf P, Gaustad P, Dobloug J, Mollnes TE, Sirnes K (1988)
   Systemic meningococcal disease: a model infection to study acute endotoxinemia in man
   Prog Clin Biol Res, 272, 263-71
   PubMed 3393567
3. Garred P, Mollnes TE, Lea T (1988)
   Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3
   Scand J Immunol, 27 (3), 329-35
   PubMed 2451274
4. Garred P, Mollnes TE, Lea T, Fischer E (1988)
   Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c
   Scand J Immunol, 27 (3), 319-27
   PubMed 2451273
5. Halstensen TS, Mollnes TE, Brandtzaeg P (1988)
   Terminal complement complex (TCC) and S-protein (vitronectin) on follicular dendritic cells in human lymphoid tissues
   Immunology, 65 (2), 193-7
   PubMed 2461343
6. Halstensen TS, Mollnes TE, Garred P, Brandtzaeg P (1988)
   Deposits of terminal complement complex and S-protein on follicular dendritic cells in human lymphoid tissue
   Adv Exp Med Biol, 237, 185-9
   PubMed 2978199
7. Heideman M, Norder-Hansson B, Bengtson A, Mollnes TE (1988)
   Terminal complement complexes and anaphylatoxins in septic and ischemic patients
   Arch Surg, 123 (2), 188-92
   PubMed 3277584
8. Hunziker T, Mollnes TE, Misiano G, Späth PJ (1988)
   Complement in chronic cutaneous lupus erythematosus
   Br J Dermatol, 118 (1), 131-3
   PubMed 3257702
9. Mellbye OJ, Frøland SS, Lilleaasen P, Svennevig JL, Mollnes TE (1988)
   Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70
   Eur Surg Res, 20 (2), 101-9
   PubMed 2455645
10. Mollnes TE, Garred P, Bergseth G (1988)
    Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation
    Clin Exp Immunol, 73 (3), 484-8
    PubMed 2463123
11. Mollnes TE, Klos A, Tschopp J (1988)
    Identification of a human C5 beta-chain epitope exposed in the native complement component but concealed in the SC5b-9 complex
    Scand J Immunol, 28 (3), 307-12
    PubMed 2461581
12. Mollnes TE, Lachmann PJ (1988)
    Regulation of complement
    Scand J Immunol, 27 (2), 127-42
    PubMed 3277261
13. Mollnes TE, Tambs KE, Myreng Y, Engebretsen LF (1988)
    Acute phase reactants and complement activation in patients with acute myocardial infarction
    Complement, 5 (1), 33-9
    PubMed 2448082
14. Pettersen HB, Johnson E, Mollnes TE, Garred P (1988)
    Synthesis of soluble C3 and C9 neoepitopes by human alveolar macrophages in vitro
    Scand J Immunol, 28 (4), 431-4
    PubMed 2461585
15. Sandberg G, Stenvinkel C, Mollnes TE (1988)
    Demonstration of C3d and the terminal complement complex on thymic large granular lymphocytes and common thymocytes after incubation with naturally thymocytotoxic serum
    Int Arch Allergy Appl Immunol, 87 (3), 239-46
    PubMed 3264545
16. Thorlacius S, Mollnes TE, Garred P, Aarli JA, Matre R, Tönder O, Halvorsen K (1988)
    Plasma exchange in myasthenia gravis: changes in serum complement and immunoglobulins
    Acta Neurol Scand, 78 (3), 221-7
    PubMed 3227807
17. Videm V, Fosse E, Mollnes TE, Garred P (1988)
    Complement activation by extracorporeal circulation: effects of precoating a membrane oxygenator circuit with human whole blood
    Scand J Thorac Cardiovasc Surg, 22 (3), 251-6
    PubMed 3227328

Publications 1987

1. Fosse E, Mollnes TE, Ingvaldsen B (1987)
   Complement activation during major operations with or without cardiopulmonary bypass
   J Thorac Cardiovasc Surg, 93 (6), 860-6
   PubMed 3494886
2. Fosse E, Mollnes TE, Osterud A, Aasen AO (1987)
   Effects of methylprednisolone on complement activation and leukocyte counts during cardiopulmonary bypass
   Scand J Thorac Cardiovasc Surg, 21 (3), 255-61
   PubMed 2964081
3. Fosse E, Mollnes TE, Aasen AO, Trumpy JH, Stokke T (1987)
   Complement activation following multiple injuries
   Acta Chir Scand, 153 (5-6), 325-30
   PubMed 3499041
4. Mollnes TE, Harboe M (1987)
   Immunohistochemical detection of the membrane and fluid-phase terminal complement complexes C5b-9(m) and SC5b-9. Consequences for interpretation and terminology
   Scand J Immunol, 26 (4), 381-6
   PubMed 3685888
5. Mollnes TE, Lachmann PJ (1987)
   Activation of the third component of complement (C3) detected by a monoclonal anti-C3'g' neoantigen antibody in a one-step enzyme immunoassay
   J Immunol Methods, 101 (2), 201-7
   PubMed 2440954
6. Mollnes TE, Tschopp J (1987)
   A unique epitope exposed in native complement component C9 and hidden in the terminal SC5b-9 complex enables selective detection and quantification of non-activated C9
   J Immunol Methods, 100 (1-2), 215-21
   PubMed 2439601
7. Mollnes TE, Vandvik B, Lea T, Vartdal F (1987)
   Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex
   J Neurol Sci, 78 (1), 17-28
   PubMed 3572448

Publications 1986

1. Mollnes TE, Lea T, Mellbye OJ, Pahle J, Grand O, Harboe M (1986)
   Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex
   Arthritis Rheum, 29 (6), 715-21
   PubMed 3718564
2. Mollnes TE, Lea T, Rogde S, Tedesco F (1986)
   The terminal complement complex in sera deficient in the eighth component of complement (C8)
   Scand J Immunol, 24 (3), 307-12
   PubMed 3749815
3. Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M (1986)
   Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro
   Clin Exp Immunol, 65 (1), 73-9
   PubMed 3641694
4. Mollnes TE, Paus A (1986)
   Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis
   Arthritis Rheum, 29 (11), 1359-64
   PubMed 3778542
5. Tschopp J, Mollnes TE (1986)
   Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor
   Proc Natl Acad Sci U S A, 83 (12), 4223-7
   PubMed 2424021

Publications 1985

1. Mollnes TE (1985)
   Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay
   Scand J Immunol, 21 (6), 607-13
   PubMed 3895396
2. Mollnes TE (1985)
   Early- and late-phase activation of complement evaluated by plasma levels of C3d,g and the terminal complement complex
   Complement, 2 (2-3), 156-64
   PubMed 3878764
3. Mollnes TE, Frøland SS, Harboe M (1985)
   Increased plasma levels of the terminal complement complex in patients with evidence of complement activation
   Complement, 2 (2-3), 175-84
   PubMed 3878765
4. Mollnes TE, Lea T, Frøland SS, Harboe M (1985)
   Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex
   Scand J Immunol, 22 (2), 197-202
   PubMed 2412280
5. Mollnes TE, Lea T, Harboe M, Tschopp J (1985)
   Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma
   Scand J Immunol, 22 (2), 183-95
   PubMed 4035298

Publications 1984

1. Mollnes TE, Lea T, Harboe M (1984)
   Detection and quantification of the terminal C5b-9 complex of human complement by a sensitive enzyme-linked immunosorbent assay
   Scand J Immunol, 20 (2), 157-66
   PubMed 6474098